Atherosclerosis is the most common cause of both carotid and coronary steno-occlusive disease. Rupture of an atherosclerotic plaque may lead to the formation of an overlying thrombosis resulting in complete arterial occlusion or downstream embolism. Clinically, this may manifest as a stroke or acute myocardial infarction, the overall leading causes of mortality and disability in developed countries. In this article, we summarize current concepts of the development of vulnerable plaque and provide an overview of commonly used imaging methods that may suggest/indicate atherosclerotic plaque vulnerability.
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INTRODUCTION
Atherosclerotic diseases, including stroke and acute coronary syndromes, are the leading causes of both mortality and disability in industrialized countries 1 . Although atherosclerosis itself is a relatively benign process of slow (lifelong) but gradual vascular remodeling, it may be abruptly complicated by rupture or erosion of an atherosclerotic plaque with an overlying thrombosis precipitating acute ischemic event. Currently, two different approaches are used for the identification and management of patients at risk of acute vascular events: 1) in those with stable coronary syndromes, the extent of ischemia is evaluated and in the case of large "area-inrisk" ,revascularization is considered, 2) in "event-naive" subjects, identification of the risk of future events mainly relies on the estimations derived from the cumulation of "classic" risk factors. These may be calculated using the Systematic Coronary Risk Evaluation ("SCORE") system or the Framingham risk equation 2, 3 . Nevertheless, because acute vascular events occur (in absolute numbers) more commonly in non-high-risk patients (due simply to their significantly larger representation in the population) and considering that the majority of acute vascular events are caused by rupture or erosion of hemodynamically non-significant atherosclerotic plaques 4 (largely outnumbering flow-limiting stenoses), one is not surprised that there is constant effort in the search for more individualized approaches to risk stratification. During the past decade, development of new tools allowing us to better understand the atherosclerotic process as well as to more precisely characterize the structure and potential vulnerability of the plaque, has been the focus of considerable attention 5 .
INITIATION OF ATHEROSCLEROTIC PLAQUE
Few human diseases have a longer "incubation" period than atherosclerosis typically manifesting without warning after several decades. Accelerated by poor diet and diminished physical activity, it has become epidemic in developed as well as "westernized" countries. Indeed, intimal lesions can be found in many such persons, even in their early decades of life. Over the last century, there has been a remarkable evolution in understanding the pathogenesis of atherosclerosis including detailed description of processes within the vascular wall, providing important concepts for future research.
The layer of endothelial cells constitutes the crucial contact surface with blood and is one of the only surfaces, either natural or artificial, that can maintain blood in a liquid state during protracted contact. The second major cell type, smooth muscle cells localized in the arterial media, has many important functions such as to contract and relax in order to control blood flow. Interestingly, with aging, human arteries develop a more complex (thicker) intima despite the absence of atherosclerosis.
Currently, atherosclerosis is viewed as an inflammatory disease, while experiments with dietary modulation performed in the early 20th century clearly proved cholesterol plays a key role in promoting atherosclerosis 6 . On initiation of an atherogenic diet (rich in cholesterol and saturated fats), small lipoprotein particles accumulate in the intima, particularly at sites of hemodynamic strain 7, 8 . Susceptible to oxidative stress, they undergo chemical modification that initiates the attraction of leukocytes,-a process orchestrated by leukocyte adhesion molecules. Leukocytes begin to adhere to arterial endothelium, penetrate the endothelial cells and scavenge lipid particles, becoming foam cells 9 . The foam cells not only serve as a reservoir for excess lipid, they are a rich source of inflammatory mediators, promoting inflammation and progression of the lesion 10, 11 . While the early events in the atheroma involve primarily altered endothelial function and consequently recruitment and accumulation of leukocytes, the evolution into more complex plaques also involves smooth muscle cells.
PROGRESSION OF ATHEROSCLEROTIC PLAQUE
If the stimulus for atherogenesis is amplified, foam cells disintegrate and release lipid into the extracellular space, forming a mostly acellular lipid pool 12, 13 . At the same time, activated smooth muscle cells migrate into the intimal layer and proliferate, strikingly increasing its ability to produce collagen and repair and maintain the fibrous cap 14 . With the thickening of the plaque, its deeper layers may become hypoxic, triggering angiogenesis and micro vessel proliferation from the adventitial vasa vasorum. These neovessels are, however, immature, fragile and prone to bleeding that yields rapid changes in plaque size and composition and may promote the transition from a stable into an unstable lesion 15 . This detrimental process of plaque destabilization is also supported by the activation of matrix metalloproteinases and inflammation-activated apoptosis or necrosis of the surrounding cells and aggravated by hemorrhage of erythrocytes with cholesterol-rich membranes, particularly in hypercholesterolemic patients 16, 17 . It is now evident that plaque progression is not a gradual process but rather a series of episodes of clinical injury and healing. This concept is supported by pathological findings of distinct plaque laminations clearly demonstrating stepwise plaque progression. It has also become clear that these "crises of inflammation" are dispersed over the arterial tree suggesting the diffuse effect of risk factors 18 . In the case of an acute event, a thrombogenic cascade is activated due to exposure of highly thrombogenic fatty core components leading to the development of an acute occlusive thrombus. If, instead of plaque rupture, erosion occurs, the process of occlusion may be counterbalanced by the fibrinolytic system. The end result may be either thrombus progression with the risk of occlusion, distal embolization or thrombus regression and healing that may again be evidenced as plaque lamination. Most importantly, several plaque characteristics are suggested to portend the risk of instability while high dose statin therapy has been shown to stabilize plaque volume 19 .
VULNERABLE PLAQUE VS. MYOCARDIUM AT RISK
Coronary arteriography, first performed by Mason Sones in 1959, was a pioneering method in the evaluation of the extent of coronary artery disease. It soon became the gold standard and is currently the most widely used invasive procedure in cardiovascular medicine. Its primary goal is to identify and localize significant coronary stenosis suggesting that the more proximal and diffuse the disease, the more pronounced is the benefit from revascularization 20 . However, its specificity in determining the significance of coronary artery disease in patients with borderline stenosis has been repeatedly questioned 21 . Fractional flow reserve has emerged as an invasive method for evaluating the hemodynamic relevance of coronary stenosis by means of measuring the relative poststenotic pressure drop during maximal coronary vasodilation. Currently, it is considered the most direct way for assessing the hemodynamic significance of individual coronary lesions and is recommended in all patients with borderline stenosis without non-invasive measurement of the extent of ischemia. Similarly, carotid arteriography is considered the gold standard in evaluating the extent of atherosclerotic carotid artery disease. Although it has been repeatedly shown that the significance of carotid artery stenosis is related to the risk of early recurrence of ischemic stroke 22, 23 , its predictive value of major events in asymptomatic patients is low 24, 25 . This, however, may be improved by the measurement of cerebrovascular reserve (similarly to coronary reserve) such as with transcranial Doppler ultrasound 26 . It may thus be simplified, that both coronary and carotid arteriography in stable patients can identify high-risk territory, but it provides little information about the actual risk of plaque destabilization. It is thus believed that the diagnostic accuracy may be improved by evaluating the vulnerability of the atherosclerotic plaque. Moreover, knowledge of the composition of the vessel wall and identification of "hot spots" within the vascular territory is attractive for interventional cardiologists since it could allow optimizing percutaneous interventions such as avoiding the "hot lesion" being only partially covered or even crushed by the edge of a stent.
NON-INVASIVE PLAQUE IMAGING
Multidetector CT (MDCT) angiography has emerged as the leading platform for non-invasive plaque imaging due to its high speed and resolution. Current generation 320-slice systems can image the entire heart within a single ultrafast rotation at sub-millimeter 27 resolution and offers high-quality images in both carotid and coronary territory (Fig. 1) . Besides detecting lumen stenosis, it provides an estimation of plaque volume. The latter has been hypothesized to even better reflect disease severity 28, 29 . In addition, it may help in detecting some of the features associated with plaque vulnerability, such as: 1) positive vessel remodeling (dilation of the vessel wall to maintain sufficient lumen diameter), 2) presence of spotty calcifications and 3) lower plaque density -lower suggests a more lipid core or even plaque hemorrhage [29] [30] [31] ( Table 1) . Whenever identified in patients with atherosclerotic risk factors, cumulation of these features have been shown to predict the occurrence of subsequent acute coronary syndrome 31 . On the other hand, the presence of solid calcium confers stability, resulting in protection 32 . Nevertheless, MDCT is suboptimal in identifying thin fibrous caps due to halo or edge blur effect and its major worrying limitation is radiation exposure 33 . This aside, MDCT currently represents the first-line non-invasive method in the search for vulnerable plaques.
Magnetic resonance imaging (MRI) can provide an image of the biological characteristics of tissue (such as water, lipid and fibrous content) using different contrast weightings. However, due to its low spatial resolution, it is best suited for large, static arteries such as carotids (though MRI is improved using dedicated surface coils) while coronary arteries are difficult to image owing to their small dimension and continuous motion 34 . Its best potential lies in its ability to estimate the thickness of the fibrous cap and the presence of intraplaque hemorrhage. Thick, likely stable, fibrous caps appear as a juxtaluminal band of low signal on time-of-flight images, whereas in plaques with a thin fibrous cap, the dark juxtaluminal band is absent 35 . When a fibrous cap ruptures, the absence of a dark band is accompanied by the presence of a bright gray region adjacent to the lumen, corresponding to the plaque hemorrhage and/or mural thrombus 36 . Intraplaque hemorrhage is currently considered a high-risk for plaque instability and MRI is not only able to detect the presence of plaque hemorrhage (based on the presence of metahemoglobin or hemosiderin), it is also able to age plaque hemorrhage using specific imaging techniques 37 . Carotid ultrasonography (Fig. 2a) is a first-line method for quantifying the degree of stenosis due to its low cost. It may, however, also be used to estimate plaque vulnerability based on the plaque surface and composition 38, 39 . First, smooth plaques without any sign of ulceration or irregularity indicate a stable plaque while irregularities and particularly frank ulcerations significantly increase the risk of cerebrovascular events as demonstrated by the NASCET study 40 . Second, Geroulakos et al 41 classified plaques into five types based on echogenicity with types 1 and 2 (both predominantly anechogenic) similar to CT fatty plaques. Third, using micro-bubble contrast, it is possible to estimate the degree of neovascularization, linked to the degree of inflammation, based on plaque contrast enhancement 42 . This technique is similar to gadolinium based contrast enhancement that may be used to estimate neovascularization in MRI (ref. 43, 44 ). Transcranial Doppler ultrasound is another portable and low cost sonographic method used primarily to evaluate flow within cerebral vasculature. It is also able to detect high intensity transient signals (Fig. 2b) , which correlate with solid particles travelling within the artery. Importantly, it has been demonstrated that detection of such signals is linked to increase in risk of a cerebrovascular event up to 4 times and thus may indirectly reflect the plaque vulnerability 45, 46 . Nuclear imaging modalities are intrinsically designed to image systemic disorders such as atherosclerosis due to their whole-body and targeted-imaging capabilities. For several reasons, such as increased spatial resolution (4-5mm compared to 1-1.6cm in SPECT), positron emission tomography (PET) has been used in most studies on nuclear imaging in atherosclerosis. Labelled fluorodeoxyglucose (FDG) is currently the most validated tracer for imaging plaque inflammation. In particular, FDG progressively accumulates in metabolically active cells such as activated macrophages. Whereas imaging of coronary arteries is challenging, owing mainly to intense tracer uptake of adjacent myocardium, high FDG uptake in carotid plaques has been shown to correlate with macrophage accumulation 47, 48 . Moreover, carotid FDG PET is highly reproducible and appears to be able to reflect therapeutic interventions, suggesting a possible role in treatment monitoring 49 . Finally, apart from glucose uptake, numerous other metabolic and signalling pathways associated with vulnerable plaque (such as labelled low density lipoproteins, matrix metalloproteinase inhibitors 50 , chemotactic proteins and others) may be targeted with nuclear imaging. Such highly investigational targeted molecular imaging is, however, no longer restricted to PET but is being investigated in other modalities, such as MRI as well as MDCT using dedicated agents.
INTRAVASCULAR PLAQUE IMAGING
Intravascular ultrasound (IVUS) is one of the first techniques used to assess plaque morphology and is currently widely used in routine clinical practice (Fig. 3) . IVUS employs miniaturized ultrasound transducers to obtain real-time cross-sectional tomographic images perpendicular to the long axis during pull-back. The intensity of the backscatter signal is processed in gray scale with a spatial resolution of 150 μm, that determines both the lumen stenosis and several signs of plaque vulnerability [51] [52] [53] , notably the presence of an echolucent core (probably representing a lipid-rich core), positive vessel wall remodeling, plaque length and spotty calcifications (IVUS defined as an arc of calcified plaque that encompasses less than 1/4 of the cross-sectional image). On the other hand, it does not permit identification of the cap thickness that is below the spatial resolution of IVUS systems. While grayscale IVUS can effectively differentiate calcified from non-calcified plaques, it cannot accurately determine non-calcified plaque tissue composition due to the limitations of post-processing. However, spectral analysis of the IVUS backscatter signal before demodulation and scan conversion can overcome some of these limitations and has given rise to a virtual histology IVUS (VH-IVUS) (Fig. 3) . With VH-IVUS, plaque components are usually categorized into 4 types: fibrous, fibrofatty, calcified necrotic and calcified which are displayed as a color-coded map 54, 55 . Moreover, it can further differentiate thin cap fibroatheroma (TCFA) defined as a necrotic core extending into the lumen surface. The diagnostic accuracy of VH-IVUS was validated against histology and has shown a sensitivity, specificity and predictive accuracy for detecting a necrotic core of 67.3%, 92.9% and 88.3%, respectively 54, 56 . In the landmark PROSPECT trial 57 , which evaluated the natural history of all >30% stenosed coronary plaques identified by 3-vessel grayscale and VH-IVUS imaging in acute coronary syndrome patients, the presence of TCFAs assessed by VH-IVUS correlated well with subsequent risk of major adverse cardiac events (hazard ratio 3.35) at a median follow-up of 3.4 years, however, the predictive accuracy was low. The authors acknowledged that of 595 TCFAs, only 26 became the culprit site of the subsequent event. Interestingly, in a subgroup analysis, patients with higher residual atherosclerotic disease (more necrotic core and TCFAs) had significantly higher nonculprit events compared to those without (P=0.0001), supporting the concept that greater residual coronary disease portends greater future risk 58 . Optical coherency tomography (OCT) uses reflected near-infrared light to obtain unsurpassed high-resolution images 59 ( Table 2 ). Due to attenuation of the signal by blood, visualization is performed through brisk saline or contrast flushing, promoted by very rapid data acquisition (maximal pullback speed up to 40 mm/sec). Its superb image resolution allows accurate recognition of features such as plaque rupture or thrombi (Fig. 4) , cap thickness (considered thin if ≤ 65 μm) or even plaque erosion. OCT was also shown to permit quantification of macrophage content in the fibrous cap 60 and subintimal lipid accumulation. Positively remodeled plaques have been shown to exhibit greater lipid content and thinner fibrous caps 61 . In patients with diabetes, OCT plaque analysis demonstrated greater lipid content, calcification and thrombus compared to non-diabetic patients consistent with the recognition that diabetic subjects have more complex and diffuse coronary disease 62 . Moreover, those with poorly controlled diabetes had the highest lipid content and thinner fibrous caps. Interestingly, serial OCT imaging has shown increasing thickness of the fibrous cap in stable angina patients following statin therapy 63 . Although OCT seems to provide the most reproducible images, its major drawback is low penetration/field of view and particularly the need for flushes (or even balloon occlusions), which limits its use in larger arteries such as carotids.
Finally, near infrared spectroscopy (NIRS) is a newer clinical intravascular imaging modality that detects and quantifies the presence of lipid within the vessel wall based on the specific absorption pattern of near-infrared light by cholesterol molecules. Since it provides minimal anatomic information, it is mounted on IVUS acquired structural data and presented as a probability map called a "chemogram". The X-axis of the chemogram indicates the pullback position in millimeters and the Y-axis indicates the circumferential position in degrees as though the coronary vessel has been split open along its longitudinal axis. It has been validated against coronary autopsy specimens and proven superior to IVUS alone in the detection of lipid core plaques 64 . While its value in clinical use is currently under investigation in large prospective studies, there have already been reports of testing combined NIRS-OCT probes that may further improve the accuracy of the system 65 .
CONCLUSION
Atherosclerosis is currently viewed as a dynamic process with episodes of progression and healing, that may or may not clinically manifest depending on many factors. It has become evident that the concept of "ischemic burden", based solely on the degree of stenoses, is oversimplified and there is constant requirement for better patient risk stratification. Particularly over the last decade, understanding of the natural course of atherosclerosis has significantly improved and the concept of "vulnerable plaque (patient)" is proposed. Currently, there are a variety of imaging methods that may aid in the detection of vulnerable plaque, however, the data show that no single parameter can reliably predict future events. The acquisition of such additional information also comes with either higher cost, radiation or additional intravascular manipulation. Therefore, albeit the concept of vulnerable plaque appears very attractive and promising in tailoring individual patient therapy, its clinical use is still in its infancy and the essential questions including when and in whom to apply such an investigation still need to be answered.
Search strategy and selection criteria
We examined studies and articles from various resources (e.g. PubMed, MEDLINE). The search terms used included atherosclerosis, vulnerable plaque, coronary arteries, carotid arteries, non-invasive imaging, intracoronary imaging. Citations from journals with high impact factors were given special weight. Only English language papers were reviewed.
ABBREVIATIONS
MDCT / CT, multidetector computed tomography; MRI, magnetic resonance imaging; SPECT, single-photon emission computed tomography; PET, positron emission tomography; FDG, fluorodeoxyglucose; IVUS, intravascular ultrasound; VH-IVUS, virtual-histology intravascular ultrasound; TCFA, thin cap fibroatheroma; OCT, optical coherence tomography; NIRS, near infrared spectroscopy.
